Is Nutex Health (NUTX) Undervalued Following Mixed Third Quarter Results?

Nutex Health (NUTX) has drawn fresh attention after reporting third quarter and nine month 2026 results, with quarterly revenue and profit declining while year to date net income rose sharply despite softer sales.

The earnings update landed alongside a sharp reset in Nutex Health’s share price, with the stock down 9.4% on a 1-day basis and 16.1% over 30 days, but still showing a 15.7% year to date share price return and a 390.4% three year total shareholder return. This suggests long term holders have seen strong gains even as short term momentum has cooled.

Scan how Nutex Health compares to other hospital and healthcare operators by reviewing a curated group of list of solid balance sheet and fundamentals (23 results).

After that mix of softer quarterly figures, a much stronger year to date profit line, and a pullback in Nutex Health’s share price, the question now is whether most of the upside has already played out or not.

Most Popular Narrative: 42% Undervalued

Nutex Health closed at $171.41, while the analyst consensus Narrative on Simply Wall St pegs fair value at $296.17 using a 7.24% discount rate. That gap underpins a view that current pricing may leave a sizeable valuation cushion if the thesis holds.

Expansion of Nutex Health micro hospitals at a stated pace of 3 to 5 openings per year, supported by a cash position of about US$205 million to US$250 million and low bank and equipment debt of roughly US$40 million to US$43 million, can add new capacity that contributes to future revenue and earnings.

See why 21 investors see Nutex Health as 42% undervalued.

Result: Fair Value of $296.17 (UNDERVALUED)

Still, Nutex Health leans heavily on arbitration under the No Surprises Act. Any rule change or weaker win rates could quickly challenge this upbeat valuation story.

Find out about the key risks to this Nutex Health narrative.

Next Steps

If Nutex Health’s mix of sharp gains and clear pressure points feels split to you, that is the right instinct, and you should test it against the underlying data, including the 5 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Nutex Health?

If Nutex Health has sharpened your focus, do not stop there. Broaden your watchlist with other clear setups that could complement or contrast this position.

• Target durable compounding potential by filtering for consistently priced opportunities using the 32 high quality undervalued stocks.
• Strengthen your income stream by scanning companies that feature the kind of payouts highlighted in the 6 dividend fortresses.
• Dial down portfolio stress by focusing on sturdier balance sheets through the 29 resilient stocks with low risk scores.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com